Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Net (loss) income $ (6,265) $ 550
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Realized loss on marketable debt securities 18 107
Depreciation and amortization 1,686 1,292
Amortization of debt discount 146 20
Amortization on operating lease right-of-use assets 110 85
Stock-based compensation expense 1,589 947
Accounts receivable allowances 0 (147)
Credit loss expense, direct write-off 0 230
Inventory reserve (69) 1
Changes in operating assets and liabilities:    
Accounts receivable 1,197 (864)
Inventory 152 (336)
Prepaid expenses and other current assets (2,122) (2,107)
Deferred tax asset (2,612) (96)
Other assets 847 0
Accounts payable and accrued expenses 2,376 (2,661)
Accrued diagnostic services (46) (656)
Accrued advertising and other allowances (16) 52
Deferred revenue (752) 443
Operating lease liabilities (459) (80)
Income tax payable (273) (341)
Other liabilities (626) 4,037
Net cash (used in) provided by operating activities (5,119) 476
Cash flows from investing activities    
Business acquisitions, escrow received 0 478
Asset acquisitions, net of cash acquired 0 (2,904)
Proceeds from sales of marketable securities 3,374 1,291
Capital expenditures (939) (517)
Net cash provided by (used in) investing activities 2,435 (1,652)
Cash flows from financing activities    
Proceeds from issuance of note payable 2,460 7,600
Repurchases of common shares 0 (541)
Repurchase of common stock for payment of statutory taxes due on cashless exercise of stock option 0 (5,379)
Repayment of note payable (189) 0
Net cash provided by financing activities 2,271 1,680
(Decrease) increase in cash, cash equivalents and restricted cash (413) 504
Cash, cash equivalents and restricted cash at the beginning of the period 2,149 9,109
Cash, cash equivalents and restricted cash at the end of the period 1,736 9,613
Supplemental disclosures:    
Income Taxes Paid, Net 318 1,500
Interest payment on the promissory notes 642 203
Noncash Investing and Financing Items [Abstract]    
Financed capital expenditures 0 1,623
Common stock issued in asset acquisition $ 0 $ 1,000